IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Paramesu Biotech IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Hyderabad and caters to Agro sector. Pantomath Capital Advisors is the merchant banker of Paramesu Biotech IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 7th November 2024.
Paramesu Biotech IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
281.87 cr.
Sector: Agro
IPO so far:
19
Merchant Banker:
Pantomath Capital
IPO by BRLM so far:
9
City:
Hyderabad
IPO so far:
4
Revenue (annualised):
₹
818.78
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 18.16x
Paramesu Biotech IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Pantomath Capital Advisors Private Limited is the book-running lead manager of the Paramesu Biotech IPO. [●] is the Registrar for Paramesu Biotech IPO.
Paramesu Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Paramesu Biotech IPO, based in Hyderabad, operates in the Agro sector with a focus on . The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Paramesu Biotech IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Paramesu Biotech IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Paramesu Biotech IPO allotment status on the registrars website, [●]. Paramesu Biotech IPO refund dates are [●].
Paramesu Biotech IPO is expected to be listed on [●].
The upper price band for the Paramesu Biotech IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Paramesu Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Paramesu Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Paramesu Biotech IPO is finalised.
The merchant banker for Paramesu Biotech IPO is Pantomath Capital Advisors Private Limited . Pantomath Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Paramesu Biotech IPO RHP for further details.
The registrar for Paramesu Biotech IPO is [●]. Investors can go to [●] registrar website for IPO allotment status, refund processing, and other queries related to Paramesu Biotech IPO through their official website or helpline.
Paramesu Biotech IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 281.87 Cr.
Sector: Agro
IPO so far:
19
Merchant Banker:
Pantomath Capital
IPO by BRLM so far:
9
City:
Hyderabad
IPO so far:
4
Revenue (annualised):
₹ 81.52 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 18.16x
Paramesu Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Paramesu Biotech Financial Review Page
Merchant Banker(s) of Paramesu Biotech IPO: Pantomath Capital Advisors Private Limited
Paramesu Biotech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Paramesu Biotech IPO listed at a listing price of against the offer price of .
The current market price of Paramesu Biotech is .
Why Us?
